Study of the Clinical Profile and Site Proclivity of Extrapulmonary Tuberculosis at Tertiary Care Center of Rohilkhand Region, Bareilly
Abhishek Kumar, Sanjay Bansal, VK Tiwari, Rajat Agarwal, Rishi K Saini, Javed Khan
Citation Information :
Kumar A, Bansal S, Tiwari V, Agarwal R, Saini RK, Khan J. Study of the Clinical Profile and Site Proclivity of Extrapulmonary Tuberculosis at Tertiary Care Center of Rohilkhand Region, Bareilly. Int J Adv Integ Med Sci 2016; 1 (3):95-97.
To study the clinical profile and site proclivity of extrapulmonary tuberculosis (EPTB) at tertiary care center of Rohilkhand region, Bareilly.
Materials and methods
Among 329 patients, the study was conducted on 108 patients with EPTB. The analysis included patients who were diagnosed for EPTB between May 1, 2015 and October 31, 2015 in a tertiary care hospital, Rohilkhand region, Bareilly, Uttar Pradesh.
Results
Among the EPTB cases studied, 62 (57.4%) were males. About 96 (88.8%) patients received Category (CAT)1 treatment and 12 (11.1%) patients received CAT2 treatment. Overall, the total number of different types of EPTB cases included lymph node (n = 44, 40.7%), human gastrointestinal tract (n = 18, 16.6%), pleura (n = 34, 31.4%), skeletal (n = 5, 4.6%), central nervous system (n = 3, 2.7%); other sites included mainly breast (n = 2, 3.2%), genitourinary (n = 1, 2.6%), and skin (n = 1, 2.6%).
Conclusion
Extrapulmonary tuberculosis still constitutes an important clinical problem. In this study, we assessed the site of predilection of EPTB patients, which constituted 32.8% of all tuberculosis cases presented to our center during the study period. Lymph node tuberculosis is the most common type.
How to cite this article
Tiwari VK, Agarwal R, Bansal S, Saini RK, Kumar A, Khan J. Study of the Clinical Profile and Site Proclivity of Extrapulmonary Tuberculosis at Tertiary Care Center of Rohilkhand Region, Bareilly. Int J Adv Integ Med Sci 2016;1(3):95-97.
Tuberculosis in relation to human immunodeficiency virus and acquired immunodeficiency syndrome. In: Iseman, MD., editor. A clinician's guide to tuberculosis. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 199-252.
; Stead, WW. Epidemiology. In: Schlossberg, D., editor. Tuberculosis and nontuberculous mycobacterial infection. Philadelphia: W.B. Saunders Company; 1999. p. 3-16.
Editorial Extra Pulmonary Tuberculosis. Indian J Tuberc 2007; 54:165-167.
Extrapulmonary tuberculosis. Indian J Med Res 2004 Oct;120(4):316-353.
; Chaulet, P.; Spinaci, S.; Harries, A. Treatment of tuberculosis: Guidelines for national programmes. Geneva: World Health Organization; 1997.
Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004 Jan;38(2):199-205.
Extrapulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2002 Oct;6(10):879-886.
Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung Dis 2005 Nov;9(11):1220-1223.
Mapping the pattern and trends of extrapulmonary tuberculosis. J Glob Infect Dis 2013 Apr;5(2):54-59.
Extra pulmonary tuberculosis: Clinical and epidemiologic spectrum of 636 cases. Arch Med Res 2004 Sep-Oct;35(5):435-441.
Smear positive EPTB at University of Gondar Hospital, Northwest Ethiopia. BMC Res 2013 Jan;6:21.
Site predilection of extrapulmonary tuberculosis: study from a tertiary care centre. Int J Res Med Sci 2015 Nov;3(11):3386-3390.
Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis 2003 Dec;7(12):1178-1185.
Patterns of extrapulmonary tuberculosis in children: a hospital based study. Indian J Community Health 2013;25(1).
Shortening the duration of treatment for cervical tuberculosis lymphadenitis. Eur Respir J 2000 Jan;15(1):192-195.
; Lam, WK.; Teoh, R. In: Davies, PD., editor. Lymph node tuberculosis in clinical tuberculosis. London, UK: Chapman and Hall Medical; 1995. p. 94-98.
